...
首页> 外文期刊>癌と化学療法 >A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1
【24h】

A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1

机译:用新型口腔抗癌药物TS-1成功治疗后切除晚期胃癌的情况

获取原文
获取原文并翻译 | 示例

摘要

We report a case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1. The patient was a 52-year-old male. Gastrointestinal fiberscopy showed advanced gastric cancer. Examinations by computed tomography revealed gastric cancer invasion of the pancreas and swollen para-aortic lymph nodes. This patient was treated by preoperative chemotherapy with oral administration of TS-1 (120 mg per day). After 3 courses of treatment of TS-1, the primary lesion and swollen lymph nodes were remarkably reduced. This chemotherapy enabled total gastrectomy in curative resection. The pathological effectiveness of chemotherapy was Grade 1b in the primary lesion and Grade 2 or 3 in the lymph nodes. The patient sustained few side effects. This preoperative chemotherapy regimen seems to be an effective and promising therapy for patients with advanced gastric cancer.
机译:我们举报了在成功治疗后用新型口腔抗癌药物TS-1进行治疗的晚期胃癌的情况。 患者是一个52岁的男性。 胃肠纤维复印件显示出晚期胃癌。 通过计算断层扫描的考试显示胰腺癌侵袭胰腺癌和肿胀的对主动脉淋巴结。 该患者通过术前化学治疗,口服施用TS-1(每天120毫克)。 3次治疗TS-1后,主要病变和肿胀的淋巴结显着降低。 这种化疗使治疗切除术中的总胃切除术。 化疗的病理有效性在淋巴结中初级病变和2或3级的1B级。 患者持续缺少副作用。 这种术前化疗方案似乎是治疗晚期胃癌患者的有效和有希望的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号